Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions

Cancer Treatment Reviews

Volumn 40, Issue 2, 2014, Pages 327-340

  Buffart, L M ^a   Galvao D A ^b   Brug, J ^a   Chinapaw, M J M ^a   Newton, R U ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Exercise; Health; Neoplasms; Physical activity; Quality of life; Review

Indexed keywords

ANTINEOPLASTIC AGENT; OXALIPLATIN; PACLITAXEL; THALIDOMIDE;

AEROBIC EXERCISE; ANDROGEN DEPRIVATION THERAPY; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CANCER THERAPY; CLINICAL PRACTICE; COLON CANCER; COLORECTAL CANCER; CONSERVATIVE TREATMENT; CYCLING; DISEASE FREE SURVIVAL; ENDOCRINE FUNCTION; EVIDENCE BASED PRACTICE; EXERCISE INTENSITY; FITNESS; GYNECOLOGIC CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE SYSTEM; INTERVENTION STUDY; LIFESTYLE MODIFICATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; MEDICAL RESEARCH; MOTIVATION; MUSCLE TRAINING; MYOPATHY; NEUROMUSCULAR FUNCTION; OVERALL SURVIVAL; PELVIC FLOOR MUSCLE TRAINING; PERIPHERAL NEUROPATHY; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PROFESSIONAL KNOWLEDGE; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; REVIEW; SOCIAL PSYCHOLOGY; SWIMMING; SYSTEMATIC REVIEW; TREATMENT DURATION; WALKING;

EXERCISE; HEALTH; NEOPLASMS; PHYSICAL ACTIVITY; QUALITY OF LIFE; REVIEW;

ACTIVITIES OF DAILY LIVING; EVIDENCE-BASED MEDICINE; EXERCISE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INDIVIDUALIZED MEDICINE; MOTOR ACTIVITY; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RESEARCH; SURVIVORS;

EID: 84888287148     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2013.06.007     Document Type: Review

References (147)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia. Cat no CAN 38, 2008, Canberra.
3. IKCnet. Dutch Cancer Registration. Survival. <>; 2012. http://www.ikcnet.nl.
4. Courneya K.S. Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc 2003, 35:1846-1852.
5. Curt G.A., Breitbart W., Cella D., Groopman J.E., Horning S.J., Itri L.M., et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000, 5:353-360.
6. Centers for Disease Control and Prevention (CDC) Cancer survivors - United States, 2007. MMWR Morb Mortal Wkly Rep 2011, 60:269-272.
7. Caspersen C.J., Powell K.E., Christenson G.M. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985, 100:126-131.
8. Fong J.Y.T., Ho J.W.C., Hui B.P.H., Lee A.M., Macfarlane D.J., Leung S.S.K., et al. Physical activity for cancer survivors: a meta-analysis of randomised controlled trials. BMJ 2012, 344:e70.
9. Speck R.M., Courneya K.S., Masse L.C., Duval S., Schmitz K.H. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010, 4:87-100.
10. Jones L.W., Liang Y., Pituskin E.N., Battaglini C.L., Scott J.M., Hornsby W.E., et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist 2011, 16:112-120.
11. Cramp F., Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochr Database Syst Rev 2012, 11:CD006145.
12. Velthuis M.J., Gasi-Idenburg S.C., Aufdemkampe G., Wittink H.M. The effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of randomised controlled trials. Clin Oncol (R Coll Radiol) 2010, 22:208-221.
13. Craft L.L., Vaniterson E.H., Helenowski I.B., Rademaker A.W., Courneya K.S. Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012, 21:3-19.
14. Mishra S.I., Schrerer R.W., Snyder C., Geigle P.M., Berlanstein D.R., Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochr Database Syst Rev 2012, CD008465.
15. Mishra S.I., Schrerer R.W., Geigle P.M., Berlanstein D.R., Topaloglu O., Gotay C.C., et al. Exercise interventions on health-related quality of life for cancer survivors. Cochr Database Syst Rev 2012, CD007566.
16. Ballard-Barbash R., Friedenreich C., Courneya K.S., Siddiqi S.M., McTiernan A., Alfano C.M. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 2012, 104:815-840.
17. Holmes M.D., Chen W.Y., Feskanich D., Kroenke C.H., Colditz G.A. Physical activity and survival after breast cancer diagnosis. JAMA 2005, 293:2479-2486.
18. Irwin M.L., McTiernan A., Manson J.E., Thomson C.A., Sternfeld B., Stefanick M.L., et al. Physical activity and survival in postmenopausal women with breast cancer: results from the Women's Health Initiative. Cancer Prev Res 2011, 4:522-529.
19. Schmitz K.H. Exercise for secondary prevention of breast cancer: moving from evidence to changing clinical practice. Cancer Prev Res 2011, 4:476-480.
20. Meyerhardt J.A., Giovannucci E.L., Holmes M.D., Chan A.T., Chan J.A., Colditz G.A., et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006, 24:3527-3534.
21. Meyerhardt J.A., Giovannucci E.L., Ogino S., Kirkner G.J., Chan A.T., Willett W., et al. Physical activity and male colorectal cancer survival. Arch Intern Med 2009, 169:2102-2108.
22. Kenfield S.A., Stampfer M.J., Giovannucci E.L., Chan J.M. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 2011, 29:726-732.
23. Richman E.L., Kenfield S.A., Stampfer M.J., Paciorek A., Carroll P.R., Chan J.M. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 2011, 71:3889-3895.
24. Courneya K.S., Booth C.M., Gill S., O'Brien P., Vardy J., Friedenreich C.M., et al. The colon health and life-long exercise change trial: a randomized trial of the national cancer institute of Canada clinical trials group. Curr Oncol 2008, 15:271-278.
25. Brown J.K., Byers T., Doyle C., Courneya K.S., Demark-Wahnefried W., Kushi L.H., et al. Nutrition and physical activity during and after cancer treatment: an American cancer society guide for informed choices. CA Cancer J Clin 2003, 53:268-291.
26. Doyle C., Kushi L.H., Byers T., Courneya K.S., Mark-Wahnefried W., Grant B., et al. Nutrition and physical activity during and after cancer treatment: an American cancer society guide for informed choices. CA Cancer J Clin 2006, 56:323-353.
27. Hayes S.C., Spence R.R., Galvao D.A., Newton R.U. Australian association for exercise and sport science position stand: optimising cancer outcomes through exercise. J Sci Med Sport 2009, 12:428-434.
28. Schmitz K.H., Courneya K.S., Matthews C., Mark-Wahnefried W., Galvao D.A., Pinto B.M., et al. American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010, 42:1409-1426.
29. Physical Activities Guidelines Advisory Committee Physical activity guidelines advisory committee report 2008, US Department of Health and Human Services, Washington (DC).
30. Comprehensive Cancer Center the Netherlands. Guideline cancer rehabilitation. <>; 2011. http://www.oncoline.nl/oncologische-revalidatie.
31. van den Berg J.P., Velthuis M.J., Gijssen B.C.M., Lindeman E., van der Pol M.A., Hillen H.F.P. Richtlijn 'Oncologische revalidatie' [guideline cancer rehabilitation]. Ned Tijdschr Geneeskd 2011, 155.
32. Steins Bisschop C.N., Velthuis M.J., Wittink H.M., Kuiper K., Takken T., van der Meulen W.J.T.M., et al. Cardiopulmonary exercise testing in cancer rehabilitation. A systematic review. Sports Med 2012, 42:367-379.
33. De Backer I., Schep G., Hoogeveen A., Vreugdenhil G., Kester A.D., van Breda E. Exercise testing and training in a cancer rehabilitation program: the advantage of the steep ramp test. Arch Phys Med Rehabil 2007, 88:610-616.
34. Rock C.L., Doyle C., Demark-Wahnefried W., Meyerhardt J., Courneya K.S., Schwartz A.L., et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 2012, 62:242-274.
35. Campbell A., Stevinson C., Crank H. The BASES expert statement on exercise and cancer survivorship. J Sports Sci 2012, 30:949-952.
36. Bull F.C., Expert Working Groups Physical activity guidelines in the U.K.: review and recommendations 2010, School of Sport, Exercise and Health Sciences, Loughborough.
37. Courneya K.S., Friedenreich C.M. Physical activity and cancer control. Semin Oncol Nurs 2007, 23:242-252.
38. Cramp F., Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochr Database Syst Rev 2008, CD006145.
39. Duijts S.F., Faber M.M., Oldenburg H.S., van Beurden M., Aaronson N.K. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors - a meta-analysis. Psychooncology 2011, 20:115-126.
40. Kraemer H.C., Wilson G.T., Fairburn C.G., Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002, 59:877-883.
41. Courneya K.S., Sellar C.M., Stevinson C., McNeely M.L., Friedenreich C.M., Peddle C.J., et al. Moderator effects in a randomized controlled trial of exercise training in lymphoma patients. Cancer Epidemiol Biomarkers Prev 2009, 18:2600-2607.
42. Courneya K.S., McKenzie D.C., Mackey J.R., Gelmon K., Reid R.D., Friedenreich C.M., et al. Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial. Cancer 2008, 112:1845-1853.
43. Carmack Taylor C.L., de Moor C., Basen-Engquist K., Smith M.A., Dunn A.L., Badr H., et al. Moderator analyses of participants in the active for life after cancer trial: implications for physical activity group intervention studies. Ann Behav Med 2007, 30:115-129.
44. Courneya K.S., Segal R.J., Mackey J.R., Gelmon K., Reid R.D., Friedenreich C.M., et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 2007, 25:4396-4404.
45. Segal R.J., Reid R.D., Courneya K.S., Sigal R.J., Kenny G.P., Prud'Homme D.G., et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009, 27:344-351.
46. Jones L.W., Eves N.D., Kraus W.E., Potti A., Crawford J., Blumenthal J.A., et al. The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. BMC Cancer 2010, 10:155.
47. National Institutes of Health Clinical Center. Effect of Tai Chi vs. structured exercise on physical fitness and stress in cancer survivors. ClinicalTrials.gov. NCT00246818. <>; 2011. http://www.clinicaltrials.gov.
48. Newton R.U., Taaffe D.R., Spry N., Gardener R.A., Levin G., Wall B., et al. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer 2009, 9:210.
49. Siew Yim L. Randomised controlled trial of physical activity with breast cancer survivors. Australian New Zealand Clinical Trials Registry. ACTRN12611000093987. <>; 2011. http://www.anzctr.org.
50. Winters-Stone K. Comparison of aerobic and resistance exercise in older breast cancer survivors. ClinicalTrials.gov. NCT00662103. <>; 2012. http://www.clinicaltrials.gov.
51. Young-McCaughan S. Comparing aerobic to resistance training in recovery from cancer. ClinicalTrials.gov. NCT00237926. <>; 2008. http://www.clinicaltrials.gov.
52. Baumann F.T., Zopf E.M., Bloch W. Clinical exercise interventions in prostate cancer patients - a systematic review of randomized controlled trials. Support Care Cancer 2012, 20:221-233.
53. Van Kampen M., De Weerdt W., Van Poppel H., De Ridder D., Feys H., Baert L. Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: a randomised controlled trial. Lancet 2000, 355:98-102.
54. Burnham T.R., Wilcox A. Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc 2002, 34:1863-1867.
55. Gibbs Z. Exercise for breast cancer patietns with lymphedema. Australian New Zealand Clinical Trials Registry. ACTRN12612000256875. <>; 2012. http://www.anzctr.org.au.
56. Cormie P. Exercise intervention trial for women with breast cancer related lymphoedema. Australian New Zealand Clinical Trials Registry. ACTRN12610000788077. <>; 2012. http://www.anzctr.org.au.
57. Kampshoff C.S., Buffart L.M., Schep G., van Mechelen W., Brug J., Chinapaw M.J. Design of the Resistance and Endurance exercise After ChemoTherapy (REACT) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of exercise interventions after chemotherapy on physical fitness and fatigue. BMC Cancer 2010, 10:658.
58. Jones L.W., Douglas P.S., Eves N.D., Marcom K., Kraus W.E., Herndon J.E., et al. Rationale and design of the Exercise Intensity Trial (EXCITE): a randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer. BMC Cancer 2010, 10:531.
59. Sprod L.K., Hsieh C.C., Hayward R., Schneider C.M. Three versus six months of exercise training in breast cancer survivors. Breast Cancer Res Treat 2010, 121:413-419.
60. Gibbs Z. Fatigue and changes to muscle strength and physical function in delayed versus immediate exercise for breast cancer survivors scheduled for radiation therapy: a randomised controlled trial. Australian New Zealand Clinical Trials Registry. ACTRN12612000646842. <>; 2012. http://www.anzctr.org.au.
61. Newton R.U., Taaffe D.R., Spry N., Cormie P., Chambers S., Gardener R.A., et al. Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?. BMC Cancer 2012, 12:432.
62. Walenkamp A, Gietema JA. Optimal timing of physical activity in cancer treatment (ACT). ClinicalTrials.gov. NCT01642680. <>; 2012. http://www.clinicaltrials.gov.
63. Hafeman D.M., Schwartz S. Opening the Black Box: a motivation for the assessment of mediation. Int J Epidemiol 2009, 38:838-845.
64. MacKinnon D.P., Luecken L.J. How and for whom? Mediation and moderation in health psychology. Health Psychol 2008, 27:S99-S100.
65. Schwartz A.L. Fatigue mediates the effects of exercise on quality of life. Qual Life Res 1999, 8:529-538.
66. Buffart L.M., De Backer I.C., Schep G., Vreugdenhil A., Brug J., Chinapaw M.J. Fatigue mediates the relationship between physical fitness and quality of life in cancer survivors. J Sci Med Sport 2013, 16:99-104.
67. Buffart L.M., Thong M.S., Schep G., Chinapaw M.J., Brug J., van de Poll-Franse L.V. Self-reported physical activity: its correlates and relationship with health-related quality of life in a large cohort of colorectal cancer survivors. PLoS One 2012, 7:e36164.
68. Sherman K.A., Heard G., Cavanagh K.L. Psychological effects and mediators of a group multi-component program for breast cancer survivors. J Behav Med 2010, 33:378-391.
69. Fairey A.S., Courneya K.S., Field C.J., Mackey J.R. Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions. Cancer 2002, 94:539-551.
70. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 2003, 107:499-511.
71. Wratten C., Kilmurray J., Nash S., Seldon M., Hamilton C.S., O'Brien P.C., et al. Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys 2004, 59:160-167.
72. Pierce B.L., Ballard-Barbash R., Bernstein L., Baumgartner R.N., Neuhouser M.L., Wener M.H., et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009, 27:3437-3444.
73. Chinapaw M.J., de J.N., Pallast E.G., Kloek G.C., Schouten E.G., Kok F.J. Immunity in frail elderly: a randomized controlled trial of exercise and enriched foods. Med Sci Sports Exerc 2000, 32:2005-2011.
74. Mathur N., Pedersen B.K. Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm 2008, 2008:109502.
75. Kadoglou N.P., Iliadis F., Angelopoulou N., Perrea D., Ampatzidis G., Liapis C.D., et al. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007, 14:837-843.
76. Lakka T.A., Lakka H.M., Rankinen T., Leon A.S., Rao D.C., Skinner J.S., et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE family study. Eur Heart J 2005, 26:2018-2025.
77. Irwin M.L., McTiernan A., Bernstein L., Gilliland F.D., Baumgartner R., Baumgartner K., et al. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2005, 14:2881-2888.
78. Fairey A.S., Courneya K.S., Field C.J., Bell G.J., Jones L.W., Martin B.S., et al. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial. Brain Behav Immun 2005, 19:381-388.
79. Jones L.W., Eves N.D., Peddle C.J., Courneya K.S., Haykowsky M., Kumar V., et al. Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions. Appl Physiol Nutr Metab 2009, 34:197-202.
80. Galvao D.A., Taaffe D.R., Spry N., Joseph D., Newton R.U. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010, 28:340-347.
81. Bower J.E., Ganz P.A., Tao M.L., Hu W., Belin T.R., Sepah S., et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res 2009, 15:5534-5540.
82. Lee C.C., Liu K.J., Wu Y.C., Huang T.S. Tumor necrosis factor-α Interleukin-8 and Interleukin-6 are involved in vascular endothelial cell capillary tube and network formation induced by tumor-associated macrophages. J Cancer Mol 2006, 2:155-160.
83. Buck I., Morceau F., Grigorakaki C., Dicato M., Diederich M. Linking anemia to inflammation and cancer: the crucial role of TNFalpha. Biochem Pharmacol 2009, 77:1572-1579.
84. Hong D.S., Angelo L.S., Kurzrock R. Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 2007, 110:1911-1928.
85. van Hall G., Steensberg A., Fischer C., Keller C., Moller K., Moseley P., et al. Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab 2008, 93:2851-2858.
86. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 2007, 21:863-871.
87. Schubert C., Hong S., Natarajan L., Mills P.J., Dimsdale J.E. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007, 21:413-427.
88. Seruga B., Zhang H., Bernstein L.J., Tannock I.F. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 2008, 8:887-899.
89. Pedersen B.K., Akerstrom T.C., Nielsen A.R., Fischer C.P. Role of myokines in exercise and metabolism. J Appl Physiol 2007, 103:1093-1098.
90. Pedersen B.K., Febbraio M. Muscles, exercise and obesity: skeletal muscle organ as a secretary organ. Nat Rev Endocrinol 2012, 8:457-465.
91. Petersen A.M., Pedersen B.K. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 2006, 57(Suppl. 10):43-51.
92. Pedersen B.K. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun 2011, 25:811-816.
93. Payne J.K., Held J., Thorpe J., Shaw H. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 2008, 35:635-642.
94. Galvao D.A., Nosaka K., Taaffe D.R., Peake J., Spry N., Suzuki K., et al. Endocrine and immune responses to resistance training in prostate cancer patients. Prostate Cancer Prostatic Dis 2008, 11:160-165.
95. Goodwin P., Ennis M., Pritchard K.I., Trudeau M.E., Koo J., Madarnas Y., et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002, 20:42-51.
96. Irwin M.L., Duggan C., Wang C.Y., Smith A.W., McTiernan A., Baumgartner R.N., et al. Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity and lifestyle study. J Clin Oncol 2011, 29:47-53.
97. Haydon A.M.M., MacInnis R.J., English D.R., Morris H., Giles G.G. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Gut 2006, 55:689-694.
98. Wolpin B.M., Meyerhardt J.A., Chan A.T., Ng K., Chan J.A., Wu K., et al. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 2009, 27:176-185.
99. Fairey A.S., Courneya K.S., Field C.J., Bell G.J., Jones L.W., Mackey J.R. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2003, 12:721-727.
100. Irwin M.L., Varma K., varez-Reeves M., Cadmus L., Wiley A., Chung G.G., et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale exercise and survivorship study. Cancer Epidemiol Biomarkers Prev 2009, 18:306-313.
101. Ligibel J.A., Campbell N., Patridge A., Chen W.Y., Salinardi T., Chen H., et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 2008, 26:907-912.
102. Schmitz K.H., Ahmed R.L., Hannan P.J., Yee D. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin and insulin-like growth factor axis proteins. Cancer Epidemiol Biomarkers Prev 2005, 14:1672-1680.
103. Segal R.J., Reid R.D., Courneya K.S., Malone S.C., Parliament M.B., Scott C.G., et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003, 21:1653-1659.
104. Kocer B., Sucak G., Kuruoglu R., Aki Z., Haznedar R., Erdogmus N.I. Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy. Acta Neurol Belg 2009, 109:120-126.
105. Molloy F.M., Floeter M.K., Syed N.A., Sandbrink F., Culcea E., Steinberg S.M., et al. Thalidomide neuropathy in patients treated for metastatic prostate cancer. Muscle Nerve 2001, 24:1050-1057.
106. Openshaw H., Beamon K., Synold T.W., Longmate J., Slatkin N.E., Doroshow J.H., et al. Neurophysiological study of peripheral neuropathy after high-dose paclitaxel: lack of neuroprotective effect of amifostine. Clin Cancer Res 2004, 10:461-467.
107. Openshaw H., Beamon K., Longmate J., Synold T., Slatkin N.E., Somlo G. The effect of height on paclitaxel nerve damage. J Neurooncol 2005, 74:207-210.
108. Lehky T.J., Leonard G.D., Wilson R.H., Grem J.L., Floeter M.K. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 2004, 29:387-392.
109. Leonard G.D., Wright M.A., Quinn M.G., Fioravanti S., Harold N., Schuler B., et al. Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer 2005, 5:116.
110. Wilson R.H., Lehky T., Thomas R.R., Quinn M.G., Floeter M.K., Grem J.L. Acute oxaliplatin-induced peripheral nerve hyperexcitability. J Clin Oncol 2002, 20:1767-1774.
111. Anderlini P., Buzaid A.C., Legha S.S. Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma. Cancer 1995, 76:678-679.
112. Rini B.I., Gajewski T.F. Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide. Ann Oncol 1999, 10:973-979.
113. Scruggs E.R., Rks Naylor A.J. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Pharmacology 2008, 82:83-88.
114. Prado C.M., Baracos V.E., McCargar L.J., Reiman T., Mourtzakis M., Tonkin K., et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009, 15:2920-2926.
115. Villaseñor A., Ballard-Barbash R., Baumgartner K., Baumgartner R., Bernstein L., McTiernan A., et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL study. J Cancer Surviv 2012, 6:398-406.
116. Galvao D.A., Taaffe D.R., Spry N., Newton R.U. Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis 2007, 10:340-346.
117. Galvao D.A., Spry N.A., Taaffe D.R., Newton R.U., Stanley J., Shannon T., et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int 2008, 102:44-47.
118. Galvao D.A., Taaffe D.R., Spry N., Joseph D., Turner D., Newton R.U. Reduced muscle-strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation. Prostate Cancer Prostatic Dis 2009, 12:198-203.
119. Spry N., Kristjanson L., Hooton B., Hayden L., Neerhut G., Gurney H., et al. Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur J Cancer 2006, 42:1083-1092.
120. Galvao D.A., Taaffe D.R., Spry N., Joseph D., Newton R.U. Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure. Prostate Cancer Prostatic Dis 2009, 12:233-240.
121. Jones D., Round J., de Haan A. Skeletal muscle from molecutes to movement 2004, Churchill Livingstone, London.
122. Courneya K.S. Efficacy, effectiveness, and behavior change trials in exercise research. Int J Behav Nutr Phys Act 2010, 7:81.
123. Courneya K.S., Friedenreich C.M., Quinney H.A., Fields A.L., Jones L.W., Fairey A.S. Predictors of adherence and contamination in a randomized trial of exercise in colorectal cancer survivors. Psychooncology 2004, 13:857-866.
124. Courneya K.S., Friedenreich C.M., Quinney H.A., Fields A.L., Jones L.W., Vallance J.K., et al. A longitudinal study of exercise barriers in colorectal cancer survivors participating in a randomized controlled trial. Ann Behav Med 2005, 29:147-153.
125. Courneya K.S., McKenzie D.C., Reid R.D., Mackey J.R., Gelmon K., Friedenreich C.M., et al. Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapy. Ann Behav Med 2008, 35:116-122.
126. Perna F.M., Craft L., Carver C.S., Antoni M.H. Negative affect and barriers to exercise among early stage breast cancer patients. Health Psychol 2008, 27:275-279.
127. Whitehead S., Lavelle K. Older breast cancer survivors' views and preferences for physical activity. Qual Health Res 2009, 19:894-906.
128. Ottenbacher A.J., Day R.S., Taylor W.C., Sharma S.V., Sloane R., Snyder D.C., et al. Exercise among breast and prostate cancer survivors - what are their barriers?. J Cancer Surviv 2011, 5:413-419.
129. Speed-Andrews A.E., McGowan E.L., Rhodes R.E., Blanchard C.M., Culos-Reed S.N., Friedenreich C.M., et al. Correlates of strength exercise in colorectal cancer survivors. Am J Health Behav 2013, 37:162-170.
130. Lowe S.S., Watanabe S.M., Barclay S.I., Courneya K.S. Determinants of physical activity in palliative cancer patients: an application of the theory of planned behavior. J Support Oncol 2012, 10:30-36.
131. Trinh L., Plotnikoff R.C., Rhodes R.E., North S., Courneya K.S. Correlates of physical activity in population-bases sample of kidney cancer survivors: an application of the theory of planned behavior. Int J Behav Nutr Phys Act 2012, 9:96.
132. Abraham C., Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol 2008, 27:379-387.
133. Michie S., Ashford S., Sniehotta F.F., Dombrowski S.U., Bishop A., French D.P. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy. Psychol Health 2011, 26:1479-1498.
134. Belanger L.J., Plotnikoff R.C., Clark A., Courneya K.S. A survey of physical activity programming and counseling preferences in young-adult cancer survivors. Cancer Nurs 2012, 35:48-54.
135. Gjerset G.M., Fossa S.D., Courneya K.S., Skovlund E., Jacobsen A.B., Thorsen L. Interest and preferences for exercise counselling and progamming among Norwegian cancer survivors. Eur J Cancer Care (Engl) 2011, 20:96-105.
136. Jones L.W., Courneya K.S. Exercise counseling and programming preferences of cancer survivors. Cancer Pract 2002, 10:208-215.
137. Jones L.W., Guill B., Keir S.T., Carter K., Friedman H.S., Bigner D.D., et al. Exercise interest and preferences among patients diagnosed with primary brain cancer. Support Care Cancer 2007, 15:47-55.
138. Karvinen K.H., Courneya K.S., Campbell K.L., Pearcey R.G., Dundas G., Capstick V., et al. Exercise preferences of endometrial cancer survivors. Cancer Nurs 2006, 29:259-265.
139. Karvinen K.H., Courneya K.S., Venner P., North S. Exercise programming and counseling preferences in bladder cancer survivors: a population-based study. J Cancer Surviv 2007, 1:27-34.
140. Karvinen K.H., Raedeke T.D., Arastu H., Allison R.R. Exercise programming and counseling preferences of breast cancer survivors during or after radiation treatment. Oncol Nurs Forum 2011, 38:E326-E334.
141. Lowe S.S., Watanabe S.M., Baracos V.E., Courneya K.S. Physical activity interests and preferences in palliative cancer patients. Support Care Cancer 2010, 18:1469-1475.
142. Rogers L.Q., Courneya K.S., Verhulst S., Markwell S.J., McAuley E. Factors associated with exercise counseling and program preferences among breast cancer survivors. J Phys Act Health 2008, 5:688-705.
143. Rogers L.Q., Malone J., Rao K., Courneya K.S., Fogleman A., Tippey A., et al. Exercise preferences among patients with head and neck cancer: prevalence and associations with quality of life, symptom severity, depression and rural residence. Head Neck 2009, 31:994-1005.
144. Rogers L.Q., Markwell S.J., Verhulst S., McAuley E., Courneya K.S. Rural breast cancer survivors: exercise preferences and their determinants. Psychooncology 2009, 18:412-421.
145. Stevinson C., Capstick V., Schepansky A., Tonkin K., Vallance J.K., Ladha A.B., et al. Physical activity preferences of ovarian cancer survivors. Psychooncology 2009, 18:422-428.
146. Trinh L., Plotnikoff R.C., Rhodes R.E., North S., Courneya K.S. Physical activity preferences in a population-based sample of kidney cancer survivors. Support Care Cancer 2012, 20:1709-1717.
147. Vallance J.K.H., Courneya K.S., Jones L.W., Reiman T. Exercise preferences among a population-based sample of non-Hodgkin's lymphoma survivors. Eur J Cancer Care (Engl) 2006, 15:34-43.